| Ashley Ann Walden, APRN-CNP | |
|
2115 Duncan Regional Loop, Duncan, OK 73533-1570 | |
| (580) 470-9800 | |
| Not Available |
| Full Name | Ashley Ann Walden |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 2115 Duncan Regional Loop, Duncan, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588099121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 80813 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kimberly M Weaver Md Pc | 0840344131 | 4 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
Today, the U.S. District Court for the Eastern District of New York rejected the Food and Drug Administration (FDA) decision to limit over-the-counter access to the emergency contraceptive Plan B to women over 18, ruling that it was based on politics and ideology, rather than science.
Surgical Hospital of Oklahoma, located in Oklahoma City, today announced that it has partnered with Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services.
QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.
Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads.
› Verified 5 days ago
| Entity Name | Kimberly M Weaver Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639307481 PECOS PAC ID: 0840344131 Enrollment ID: O20090820000841 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
Today, the U.S. District Court for the Eastern District of New York rejected the Food and Drug Administration (FDA) decision to limit over-the-counter access to the emergency contraceptive Plan B to women over 18, ruling that it was based on politics and ideology, rather than science.
Surgical Hospital of Oklahoma, located in Oklahoma City, today announced that it has partnered with Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services.
QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.
Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads.
› Verified 5 days ago
| Entity Name | South Central Emergency Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558663724 PECOS PAC ID: 8224212949 Enrollment ID: O20110405000201 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
Today, the U.S. District Court for the Eastern District of New York rejected the Food and Drug Administration (FDA) decision to limit over-the-counter access to the emergency contraceptive Plan B to women over 18, ruling that it was based on politics and ideology, rather than science.
Surgical Hospital of Oklahoma, located in Oklahoma City, today announced that it has partnered with Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services.
QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.
Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Ann Walden, APRN-CNP 2115 Duncan Regional Loop, Duncan, OK 73533-1570 Ph: (580) 470-9800 | Ashley Ann Walden, APRN-CNP 2115 Duncan Regional Loop, Duncan, OK 73533-1570 Ph: (580) 470-9800 |
News Archive
Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).
Today, the U.S. District Court for the Eastern District of New York rejected the Food and Drug Administration (FDA) decision to limit over-the-counter access to the emergency contraceptive Plan B to women over 18, ruling that it was based on politics and ideology, rather than science.
Surgical Hospital of Oklahoma, located in Oklahoma City, today announced that it has partnered with Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services.
QIAGEN N.V. today announced the results of operations for its quarter ended March 31, 2010. Net sales were at the high end of, and adjusted earnings per share for the first quarter 2010 exceeded the guidance provided by the Company on February 9, 2010.
Argos Therapeutics today announced that, in an interim analysis of a Phase 2 trial, its Arcelis immunotherapy targeted at HIV, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads.
› Verified 5 days ago
Crystal Carol Kizarr, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1324 N Harville Rd, Duncan, OK 73533 Phone: 580-252-1373 Fax: 580-252-8336 | |
Molli Elizabeth Emerson, APRN FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2845 W Elk Ave, Duncan, OK 73533 Phone: 580-255-9797 Fax: 855-608-6602 | |
Brett Sarita Jon Locke, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2845 W Elk Ave Bldg 100, Duncan, OK 73533 Phone: 580-255-9797 | |
Ms. Kim Raye Holland, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2601 W Elk Ave, Duncan, OK 73533 Phone: 580-251-6644 Fax: 580-251-6645 | |
Angela Tiana Essary, APNP, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1334 N Harville Rd, Duncan, OK 73533 Phone: 405-278-8006 | |
Mr. Reggie Darnell Pennypacker, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1307 Jackie Rd, Duncan, OK 73533 Phone: 580-786-4018 Fax: 580-786-4021 | |
Shelby Nicole Wilmes, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2560 W Elk Ave, Duncan, OK 73533 Phone: 802-529-6005 |